D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MCRB holding history
Seres Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MCRB overviewAll 13F holders of MCRBFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −486,353−100.0% | Sold out | Holders |
| Q1 2024 | 486,353 | $376.5K | <0.1% | +317,835+188.6% | Added | Holders |
| Q4 2023 | 168,518 | $235.9K | <0.1% | +168,518 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −43,148−100.0% | Sold out | Holders |
| Q2 2022 | 43,148 | $148.0K | <0.1% | −52,490−54.9% | Reduced | Holders |
| Q1 2022 | 95,638 | $681.0K | <0.1% | +66,506+228.3% | Added | Holders |
| Q4 2021 | 29,132 | $243.0K | <0.1% | +12,944+80.0% | Added | Holders |
| Q3 2021 | 16,188 | $113.0K | <0.1% | −36,292−69.2% | Reduced | Holders |
| Q2 2021 | 52,480 | $1.25M | <0.1% | +362+0.7% | Added | Holders |
| Q1 2021 | 52,118 | $1.07M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.